[Treatment of dissociative symptoms in borderline personality disorder with naltrexone: supplementary comments].
Schmahl
C
C
Bohus
M
M
D001883:Borderline Personality Disorder / Q000188:drug therapy* / Q000523:psychology; D004213:Dissociative Disorders / Q000188:drug therapy* / Q000523:psychology; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D009271:Naltrexone / Q000008:administration & dosage / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D016728:Self-Injurious Behavior / Q000523:psychology; D016896:Treatment Outcome
D009292:Narcotic Antagonists; D009271:Naltrexone